Literature DB >> 6269489

Immunological properties of beta-lactamases that hydrolyze cefuroxime and cefotaxime.

K Hirai, K Sato, N Matsubara, R Katsumata, M Inoue, S Mitsuhashi.   

Abstract

Antiserum against purified beta-lactamase from Proteus vulgaris GN7919 cross-reacted with beta-lactamases produced by strains of Pseudomonas cepacia in a neutralization test. Anti-P. cepacia beta-lactamase serum, however, did not show any cross-reactions with P. vulgaris beta-lactamases. Each of these enzymes can hydrolyze cefuroxime and cefotaxime.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6269489      PMCID： PMC181676          DOI： 10.1128/AAC.20.2.262

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

2.  Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

3.  Enzymatic and immunological characterization of a new cephalosporinase from Enterobacter aerogenes.

Authors:  R Letarte; M Devaud-Felix; J C Pechere; D Allard-Leprohon
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

Review 4.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

5.  Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins.

Authors:  K Sato; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

6.  Purification and properties of a new beta-lactamase from Pseudomonas cepacia.

Authors:  K Hirai; S Iyobe; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

7.  Comparative inhibition beta-lactamases by novel beta-lactam compounds.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

8.  Clavulanic acid, a novel inhibitor of beta-lactamases.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

9.  Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.

Authors:  M Matsuura; H Nakazawa; T Hashimoto; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

10.  Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri.

Authors:  M Matsuura; H Nakazawa; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191
View more
  3 in total

1.  Evolution of plasmid-coded resistance to broad-spectrum cephalosporins.

Authors:  C Kliebe; B A Nies; J F Meyer; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

2.  Development of a sensitive and specific enzyme-linked immunosorbent assay for detecting and quantifying CMY-2 and SHV beta-lactamases.

Authors:  Andrea M Hujer; Malcolm G P Page; Marion S Helfand; Bethany Yeiser; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporins.

Authors:  M Kato; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.